Global market assessment study: HPV

As of May 2018, 81 countries (42% of UN Member States, corresponding to 25% of target population) had introduced HPV into the national routine immunization schedule.3 Despite carrying the greatest share of disease burden4, LICs and MICs are lagging in the introduction of HPV vaccine. To date, the majority of the countries have self-procured HPV vaccines (74% in 2017).